Indaptus Therapeutics to Present at the Investor Summit Conference
22. März 2023 08:00 ET
|
Indaptus Therapeutics
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today...
LogicMark to Participate at the Q3 Investor Summit Conference on August 17, 2022
09. August 2022 16:05 ET
|
LogicMark, Inc.
LOUISVILLE, Ky., Aug. 09, 2022 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK) (the “Company” or “LogicMark”), a provider of personal emergency response systems (PERS), health communications...
Atossa Therapeutics to Present at the Q2 Investor Summit Conference
27. April 2022 09:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, April 27, 2022 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet...
Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference
03. März 2022 08:00 ET
|
Petros Pharmaceuticals, Inc.
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, announces today that President and Chief Commercial...
Alimera Sciences to Present at the Q1 Investor Summit Conference
02. März 2022 08:00 ET
|
Alimera Sciences, Inc.
ATLANTA, March 02, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners...
Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference
12. November 2021 09:15 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented aerosol manufacturing company focused on...
Atossa Therapeutics to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021
14. Mai 2021 09:00 ET
|
Atossa Therapeutics, Inc.
SEATTLE, May 14, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of...
InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021
14. Mai 2021 06:00 ET
|
InspireMD Inc.
TEL AVIV, Israel, May 14, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment...